HOME >> MEDICINE >> NEWS
Mailman School shares new virus identification technologies

The recent outbreaks of avian influenza throughout Asia and hemorrhagic fever due to exposure to Marburg virus in Angola highlight the importance of ensuring that as many labs as possible have access to new pathogen identification technologies as they are developed. Currently, clinical samples must sometimes be sent great distances for analysis, and the sensitivity of the technologies and equipment in labs varies greatly.

In an effort to address this, scientists from the Jerome L. and Dawn Greene Infectious Disease Laboratory in the Department of Epidemiology at Columbia University Mailman School of Public Health will share their newly developed technology platforms, which significantly reduce time needed for pathogen identification, at a week-long workshop they are hosting for scientists from around the globe whose laboratories are members of the World Health Organization (WHO) Surveillance Network. The workshop will be held at the Greene Lab from May 1 May 6, 2005.

Scientists representing institutions from the U.S., Hong Kong, Australia, Germany, Canada, Scotland, Spain, South Africa, and China (see attached list of institutions), many of whom provided input and reagents during the technology design process, will attend the Greene Lab training course. China's unprecedented participation in a global meeting of this kind provides an extraordinary opportunity for continued technology sharing and coordinated surveillance.

The workshop will provide an overview as well as hands-on sessions in the Greene Lab where participants will work in groups with Columbia faculty members using newly developed technologies that allow rapid identification of known and unknown pathogens.

"We feel that sharing these new technologies is critical to global health and consistent with our vision for a school of public health," says W. Ian Lipkin, MD, the Jerome L. and Dawn Greene Professor of Epidemiology, professor of Neurology and Pathology a
'"/>

Contact: Randee Sacks Levine
rs363@columbia.edu
212-305-8044
Columbia University's Mailman School of Public Health
3-May-2005


Page: 1 2

Related medicine news :

1. Cigarette use may explain asthma epidemic in children, says Mailman School of Public Health study
2. Mailman School of Public Health researchers analyze air quality and weather changes by 2050
3. NIH-funded program co-directed by Mailman School of PH faculty to expedite clinical research process
4. Men with no sons more at risk for prostate cancer, according to Mailman School of PH Study
5. Mailman School of Public Health researchers develop diagnostic test for pathogens
6. Mailman school researchers studying link between obesity and the urban environment
7. Mailman School of Public Health receives grant for homelessness prevention studies
8. Research by Mailman School of Public Health cites New Jerseys high healthcare costs
9. Largest survey on depression suggests higher prevalence in U.S., reports Mailman school
10. Mailman School receives grant to study reducing skin cancer risk from arsenic in water
11. Adding medication improves recovery for elderly with depression, says Pitt School of Medicine study

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mailman School shares new virus identification technologies

(Date:5/21/2013)... (PRWEB) May 21, 2013 The ... to announce four transitions for its Board of Directors. ... the Western Michigan University School of Medicine, has been ... Medical Education at the University of California San Diego, ... Executive Officer of the Nebraska Medical Center, is the ...
(Date:5/21/2013)... Lapeer, MI (PRWEB) May 21, 2013 ... Support Group meeting in Lapeer on , June 11th. ... – 8:30pm, Location: Lapeer Regional Medical Center,     Conference Room ... 48446 , These meetings are designed to assist people ... connected with one another, and to get a better ...
(Date:5/21/2013)... The birth control safety advocates at DrugRisk.com ... the contraceptive NuvaRing. A new report shows the number ... increased in recent months*. , DrugRisk was created to ... the latest safety alerts, recalls, studies and legal news. ... side effects and decide if they need legal advice. ...
(Date:5/20/2013)... 21, 2013 USA Book News announced ... to Peak Performance" won the top honor in its ... Chosen over a multitude of international titles published from ... critical acclaim from both mainstream and new age audiences ... physically and spiritually. , “The Infinity Zone” ...
(Date:5/20/2013)... The automated external defibrillator market ... categories - semi-automated and fully automated defibrillators. Based ... categories, namely, hospitals, pre-hospital, public access, alternate care, ... Automated external defibrillators play an important role in ... Considering the life-saving potential of AEDs, legislations requiring ...
Breaking Medicine News(10 mins):Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 2Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 3Health News:DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3
(Date:5/20/2013)... 20, 2013  Atlantic Pharmaceuticals, Inc., a specialty ... a unique technology to deter prescription drug abuse ... Anthony Soscia , has been chosen ... Chronicle ,s Health-Care Heroes Awards. The awards are ... to honor individuals and organizations demonstrating excellence and ...
(Date:5/20/2013)... 20, 2013 Enrollment of patients with Type ... dose-finding clinical trial of product candidate NewMet ™, ... for Type 2 diabetes. Elcelyx expects to complete enrollment ... June. Results of the trial,s primary endpoint of change ... and the read-out for long-term glucose lowering and weight ...
(Date:5/20/2013)... -- Neuralstem, Inc. (NYSE MKT: CUR) today reported that ... presented updated Phase I data from its spinal cord-derived ... of amyotrophic lateral sclerosis (ALS or Lou ... medical symposium in Bucharest, Romania , ... in Stem Cell Therapy," Dr. Feldman outlined the design ...
Breaking Medicine Technology:Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4
Cached News: